Empagliflozin Improves Left Atrial Strain in Patients With Type 2 Diabetes: Data From a Randomized, Placebo-Controlled Study

Circ Cardiovasc Imaging. 2023 Apr;16(4):e015176. doi: 10.1161/CIRCIMAGING.122.015176. Epub 2023 Apr 12.

Affiliations

¹ Department of Internal Medicine I, University Hospital Aachen (K.T., M.R., J.G., N.-U.K.H., E.A., N.M., M.L.), RWTH Aachen University, Germany.
² Department of Internal Medicine III, University Hospital Saarland, Saarland University, Homburg, Germany (M.B.).
³ Center for Translational and Clinical Research Aachen (A.P.K.), RWTH Aachen University, Germany.

^# Contributed equally.

PMID: 37071716
DOI: 10.1161/CIRCIMAGING.122.015176

No abstract available

Keywords: atrial function, left; echocardiography; glucose; sodium; stroke volume.

Publication types

Randomized Controlled Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Atrial Fibrillation*
Benzhydryl Compounds / therapeutic use
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / drug therapy
Double-Blind Method
Glucosides / therapeutic use
Heart Failure*
Humans
Hypoglycemic Agents

Substances

empagliflozin
Hypoglycemic Agents
Glucosides
Benzhydryl Compounds